Nanoparticulate Drug Delivery

Perspectives on the Transition from Laboratory to Market

By

  • Vandana Patravale, Institute of Chemical Technology, India
  • Prajakta Dandekar
  • Ratnesh Jain, Institute of Chemical Technology, India

Nanotechnology-based therapeutics, operating at scales of billionths of a metre, have great potential for future expansion in altering the scale and methods of drug delivery. The availability of these novel formulations to once-inaccessible areas of the body has greatly expanded the therapeutic window of existing drug molecules. Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology, sterility and potential toxicity. In the latter part of the book, chapters cover nanotoxicology, regulatory aspect and clinical trials, ending with an overview of several case studies and a look towards future developments.
View full description

Audience

Nanotechnologists who specialize in drug delivery; Those in R&D at companies which deal with drug delivery systems; Researchers and academics in the field of nanomedicine and pharmaceuticals

 

Book information

  • Published: October 2012
  • Imprint: Woodhead Publishing
  • ISBN: 978-1-907568-98-5


Table of Contents

Nanoparticulate systems as drug carriers: The need; Nanoparticles as drug carriers; Characterization techniques for nanoparticulate carriers; Nanotoxicology: Evaluating toxicity potential of drug-nanoparticles; Regulatory aspects of nanoparticulate drug delivery systems; Clinical trials and industrial aspects; Case studies: Nano-systems in the market.